# Eli Lilly & Co (LLY) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 59478). Listed on NYSE.
> Sector: Salud · Industry: Pharmaceutical Preparations
> Canonical URL: https://cifraresearch.com/en/empresa/LLY

## Business Profile

Profile and analysis of Eli Lilly & Co in the health care sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Eli Lilly & Co reported sales of 65.179 M$, net income of 20.640 M$ and free cash flow (FCF) of 16.813 M$ (26% FCF margin) (diluted earnings per share of 22,95 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 65.179 M$ | 27.681 M$ | 20.640 M$ | 16.813 M$ | 22,95 $ |
| 2024 | 45.043 M$ | 14.416 M$ | 10.590 M$ | 8818 M$ | 11,71 $ |
| 2023 | 34.124 M$ | 6861 M$ | 5240 M$ | 4240 M$ | 5,80 $ |
| 2022 | 28.541 M$ | 8061 M$ | 6245 M$ | 7586 M$ | 6,90 $ |
| 2021 | 28.318 M$ | 6810 M$ | 5582 M$ | 7366 M$ | 6,12 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm) — Filed on 2026-08-05
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/59478/000005947826000045/lly-20260331.htm) — Filed on 2026-04-30
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm) — Filed on 2026-02-12
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/lly-20250930.htm) — Filed on 2025-10-30
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/59478/000005947825000204/lly-20250630.htm) — Filed on 2025-08-07
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/lly-20250331.htm) — Filed on 2025-05-01
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm) — Filed on 2025-02-19
- [10-Q (Q3 2024)](https://www.sec.gov/Archives/edgar/data/59478/000005947824000245/lly-20240930.htm) — Filed on 2024-10-30

## Frequently Asked Questions

### What sector and industry does Eli Lilly & Co operate in?
Eli Lilly & Co (LLY) is listed on NYSE and operates in the Pharmaceutical Preparations industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for LLY?
In the official SEC EDGAR system under CIK 59478 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/LLY).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.